jonzobot, at .15 cents cad , the market is saying RVX  valuations is basically  worthless and the IP is not getting any enterprise value,.....  until some news on long term financing or a BP deal or something gives a new market valuation.  Best case scenario is a BP milestone CVR deal to finnace BOM2 with that BP doing the entire trial without RVX involved.  I would think a trial by BP will get across the finish line with the help of the FDA and BTD I hope we wake up one day with a halt and a BP  deal.  My question is what is the market going to value a deal with a BP,? I suppose it all depends on the terms and money involved,  Any guesses,?? I am hoping for a complete deal north of $500 million USD cash  no CVR no milestones. More likely it will be the opposite